TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Price to Book Value : 0.2334 for Oct. 15, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 0.2068 |
| October 13, 2026 | 0.2128 |
| October 12, 2026 | 0.2336 |
| October 09, 2026 | 0.2337 |
| October 08, 2026 | 0.2241 |
| October 07, 2026 | 0.2719 |
| October 06, 2026 | 0.2705 |
| October 05, 2026 | 0.29 |
| October 02, 2026 | 0.3147 |
| October 01, 2026 | 0.3118 |
| September 30, 2026 | 0.3089 |
| September 29, 2026 | 0.3118 |
| September 28, 2026 | 0.3339 |
| September 25, 2026 | 0.3339 |
| September 24, 2026 | 0.3427 |
| September 23, 2026 | 0.3575 |
| September 22, 2026 | 0.3484 |
| September 21, 2026 | 0.3247 |
| September 18, 2026 | 0.3063 |
| September 17, 2026 | 0.3275 |
| September 16, 2026 | 0.3251 |
| September 15, 2026 | 0.3155 |
| September 14, 2026 | 0.3008 |
| September 11, 2026 | 0.3146 |
| September 10, 2026 | 0.3122 |
| Date | Value |
|---|---|
| September 09, 2026 | 0.3242 |
| September 08, 2026 | 0.3386 |
| September 04, 2026 | 0.3845 |
| September 03, 2026 | 0.3642 |
| September 02, 2026 | 0.3743 |
| September 01, 2026 | 0.6543 |
| August 31, 2026 | 0.7166 |
| August 28, 2026 | 0.74 |
| August 27, 2026 | 0.7367 |
| August 26, 2026 | 0.7634 |
| August 25, 2026 | 0.7794 |
| August 24, 2026 | 0.7849 |
| August 21, 2026 | 0.7655 |
| August 20, 2026 | 0.7623 |
| August 19, 2026 | 0.7365 |
| August 18, 2026 | 0.8099 |
| August 17, 2026 | 0.7694 |
| August 14, 2026 | 0.7648 |
| August 13, 2026 | 0.7581 |
| August 12, 2026 | 0.7591 |
| August 11, 2026 | 0.7628 |
| August 10, 2026 | 0.7532 |
| August 07, 2026 | 0.7819 |
| August 06, 2026 | 0.7495 |
| August 05, 2026 | 0.766 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.07 |
| Anika Therapeutics, Inc. | 2.019 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.170 |
Price to Book Value Related Metrics
| PS Ratio | 4.342 |
| Price | 0.2377 |
| Earnings Yield | -381.2% |
| Market Cap | 16.11M |